ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001236.1|Thiotetroamide_1 # 1 # 1197 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.717	BGC0001236.1|Thiotetroamide_1 	1	1197	+	Loose	1000	25.409	lsaA	23.36	3000300	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic; pleuromutilin antibiotic	antibiotic target protection	lsa-type ABC-F protein	GTGCTGGTGACGGGCGTCGGTGCGATGACGCCGCTGGGAGCCGATGCGCCGTCGTCGTGGTCGGGGATGCTGGACGGTAAGTCGGGGGTGCGTTTCCTGGAGGAGGAGTGGGCCGCGGACCTGCCCGTGCACGTCGCGGCCGGGCTCACCGTGGACCCTGCCTCCCTGCTTCCGAGGACCGAGGCCAGGAAGCTGGACCGCGGTGAGCAGGCCGCTGTCCTCACCGCGCGCGAAGCCTGGCAGGACGCCGGCGCTCCGCAGGTCGAGCCGGAACGATGCGCCGTCGTCATCGGTACGGGGACCGGTGGTGTCCTCACCACGCTGGGCCAGGACGACGTCTTCGAGCGCGCCGGGGTTCGCCGGCTGTCGCCGTTCGCGGTCCCCATGCTGATGCCCAACGGGCCGGCCGCTTGGGTGAGCATGGACCTGGGCGCGAAGGGAGGCGCCAGGACGCCGGTGAGTGCCTGTGCGTCCGGGGCGGAAGCCCTCGCCCTGGGGCAGGATCTGATCCGCAGCGGGCGGGCGGACATAGTCGTCGCAGGTGGGGTGGAGGCATGCCTGCACCCCTTCACCATCGCGGCATTCGCCCAGATGAAGGCCCTGTCGACGCAGTCCGTGGACCCGGAGACCGTGTCCCGCCCGTTCGACGTCAAGCGGTCCGGGTTCGTCATGGGCGAGGGTGCGGGGATGATGGTGCTCGAGCGCGCCGAGTTCGCCCGGGCCCGTGGAGCACGCGCCTACGGCACGCTGGCCGGCAGTGCCGTGAGTTCGAGCGCGAACCACATCACGGCCTCCGACGCGGAAGGCCAGGCCTTCGCCATGGAACTGGCGCTGCGTGACGCCGGCCTGGCCCCGGCGGACATCGGGATCGTGCACGCCCACGCCACCTCGACGGAGTCCGGTGACCTGGCAGAGGCCGAGGCGATCGGCCGGGTGATCGGCAGCCACGCCGCGGTGACGGCGACGAAGTCGATGACAGGTCACATGATGGGCGCCGCCGGAACGGTCGGCGCCCTGGCCGCTCTGTTCGCGCTCAGGGACGGCACGGTGCCGGCCACGCGCAACCTCGACGAACTCGACCCGCGCGTGGAACTGGACGTGGTGGGCGGTGAGCGACGCACCGGCCAGTGGTCCGCGGCGCTGGCCAACTCGTTCGGGTTCGGCGGACACAACGTCAGCCTCGTCTTCACCGACTGA	VLVTGVGAMTPLGADAPSSWSGMLDGKSGVRFLEEEWAADLPVHVAAGLTVDPASLLPRTEARKLDRGEQAAVLTAREAWQDAGAPQVEPERCAVVIGTGTGGVLTTLGQDDVFERAGVRRLSPFAVPMLMPNGPAAWVSMDLGAKGGARTPVSACASGAEALALGQDLIRSGRADIVVAGGVEACLHPFTIAAFAQMKALSTQSVDPETVSRPFDVKRSGFVMGEGAGMMVLERAEFARARGARAYGTLAGSAVSSSANHITASDAEGQAFAMELALRDAGLAPADIGIVHAHATSTESGDLAEAEAIGRVIGSHAAVTATKSMTGHMMGAAGTVGALAALFALRDGTVPATRNLDELDPRVELDVVGGERRTGQWSAALANSFGFGGHNVSLVFTD	MSKIELKQLSFAYDNQEALLFDQANITMDTNWKLGLIGRNGRGKTTLLRLLQKQLDYQGEILHQVDFVYFPQTVAEEQQLTYYVLQEVTSFEQWKLERELTLLNVDPEVLWRPFSSLSGGEKTKVLLGLLFIEENAFPLIDEPTNHLDLAGRQQVAEYLKKKKHGFILVSHDRAFVDEVVDHILAIEKSQLTLYQGDFSIYEEQKKLRDAFELAENEKIKKEVNRLKETARKKAEWSMNREGDKYGNAKEKGSGAIFDTGAIGARAARVMKRSKHIQQRAETQLAEKEKLLKDLEYIDPLSMDYQPTHHKTLLTVEELRLGYEKNWLFTPISFSINAGEIVGITGKNGSGKSSLIQYLLGDFSGDSEGEATLAHQLTISYVRQDYEDNQGTLSEFAEKNQLDYTQFLNNLRKLGMERAVFTNRIEQMSMGQRKKVEVAKSLSQSAELYIWDEPLNYLDVFNHQQLEALILSVRPAMLVIEHDAHFMKKITDKKIALKS	79.92	gnl|BL_ORD_ID|1191|hsp_num:0	1298			261	672	clindamycin; quinupristin; dalfopristin; pleuromutilin
BGC0001236.1|Thiotetroamide_2 # 1255 # 2916 # -1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.684	BGC0001236.1|Thiotetroamide_2 	1255	2916	-	Loose	1000	119.013	almE	25.6	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGGAGCACGGCACCACCAAGGGAACGCTGGTCGGTGTGGTGATGGACAAGGGCTGGGAGCAGGTGGTCGGCAGCCTGGGCGTGTTGCGGTCAGGAGGTGCGTACGTCCCCGTCGACCCGCGCTGGCCGGCCCAGCGCCTCGCCGAGGTGATCGCCGCCGCGGGCCTGGAGACGATCCTCACCCAACCCGCGCTGCGCGACGTCGTCGACTGGCCCGACGGCGTCACGGTGCTGGACGTCGAAGCGCCCAGCCCGGTCGAGAACGCCGCGGTCCACACGGCGCCGGACGTCCCGGTGACACCTCGTGACGTCGCATACGTGATCTACACCTCTGGCTCCACAGGCGTCCCCAAAGGGGTGGTGATCGAGCACGGTCCGGTGGTCAACACGATCCTGGACGTCAACGACGAGCTGTCGCTCTCCGCGGACGACCGCGTCCTCGGCCTTTCGGCTCTCAACTTCGACCTGTCGGTCTACGACATCTTCGGCCCTCTCTCCGCCGGTGGCGCAGTCGTGCTGCCCGGACCGGAAGACGCACGCGAACCCGCCAGCTGGCTCGCCCTGATGGCCGAGGAGAGCGTGACGGTGTGGAACAGCGTCCCCGCCCTGATGGCCATGGTGTGCGAGCACCTGGCGTCGTCCGAGGACACGGGTCCCCGATCCCCGGGGGCTCCGTCCTCGCTGCGCGCCGTCCTCATGAGCGGGGACTGGATTCCCGTGGCCTTGCCCGACGAGATCCGGCGGTTCTTCCCTCGGGCGGCGCTGTGGAGCCTCGGGGGTGCGACCGAGGCGTCGATCTGGTCGATCTGGCATCGGATCGTGCCCGAAGATGCGACGTTGCCGTCCATCCCCTACGGCACGTCCATGCGGAACCAGAAGGTCTTTGTGGCGGATTCGCTGCTCCGGCCGCGCCCCACTTGGGTCGTGGGCGAGATCTGCATCGCCGGCGCCGGCCTGGCCCGTGAATACCTCGGCGACACGGAGAAGACCGCGAAGAGTTTCACGGTCTCTCCGTCCACCGGAGAACGCGTGTACCGGACCGGTGACTGGGGGCGTCTCCTGCCAGGCGGGGAGATCGAGTTCCTCGGCCGCGACGACATGCAGGTCAAGGTCGGCGGCTACCGGATCGAGCTCGGCGATGTGGAAGCCGCGCTGCTGCGATGTCCGGGGGTCACGGGCGCTGTCGTCACGGCCCCGGGCGACCGGAACCGTAAGCGACTCGTGGCGCACGTCGTGCTGGAGGAGGGTGCCGGGCGAACGGGAGCGGACGTCAGGAAGGCCGCGGAGGAATTCCTGCCGCCGTACATGCTTCCGTCCCTGGTGACCGTGTGGGACGCACTGCCCCTGACGGCGAACGGCAAGGTGGACCGCGCCTCACTGGCCCGGCACGAGGAGGAGCCGGACCCGGAGGATGAGAACGCTCGTCCCGACACCGAGGAGGAACAGGTCCTGCTCTCCCTGTGGAAGGACTTCTTCGAAACGTCCTCGCTGTCCGTCCTGGACAACTTCTTCGAACTGGGCGGGGACTCTCTGCGGGCCGTACGTCTGATGGCAGTGGTGAGGAAGGAACTGAACGTCTCCTTGCCCGTTTCCACGCTCTTCTCCGCACCGACGATCCGGTCTCTGGCGGGCCGCGTACAGGAGTCGCGCGCGGCCGCGTAA	MEHGTTKGTLVGVVMDKGWEQVVGSLGVLRSGGAYVPVDPRWPAQRLAEVIAAAGLETILTQPALRDVVDWPDGVTVLDVEAPSPVENAAVHTAPDVPVTPRDVAYVIYTSGSTGVPKGVVIEHGPVVNTILDVNDELSLSADDRVLGLSALNFDLSVYDIFGPLSAGGAVVLPGPEDAREPASWLALMAEESVTVWNSVPALMAMVCEHLASSEDTGPRSPGAPSSLRAVLMSGDWIPVALPDEIRRFFPRAALWSLGGATEASIWSIWHRIVPEDATLPSIPYGTSMRNQKVFVADSLLRPRPTWVVGEICIAGAGLAREYLGDTEKTAKSFTVSPSTGERVYRTGDWGRLLPGGEIEFLGRDDMQVKVGGYRIELGDVEAALLRCPGVTGAVVTAPGDRNRKRLVAHVVLEEGAGRTGADVRKAAEEFLPPYMLPSLVTVWDALPLTANGKVDRASLARHEEEPDPEDENARPDTEEEQVLLSLWKDFFETSSLSVLDNFFELGGDSLRAVRLMAVVRKELNVSLPVSTLFSAPTIRSLAGRVQESRAAA	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	99.46	gnl|BL_ORD_ID|4935|hsp_num:0	5928			300	1635	colistin A; colistin B
BGC0001236.1|Thiotetroamide_3 # 3143 # 9949 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.707	BGC0001236.1|Thiotetroamide_3 	3143	9949	-	Loose	400	29.6462	Erm(36)	35.71	3000605	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGGCCTGCCGCTACCCGGGCGGCATGAACACCCCGGAGCGCCTGTGGGCCCTGGTCGACGAGGGCCGGGACGTCATCACCGACTTCCCCGACAACCGGGAGTGGCACACCGAGGACCTCTACGACCCGAGCTTCGTGCGGCAGGGCGGGTTCCTCCACGACGCGGACCTCTTCGACGCCGACTTCTTCGGGATCAGACCCGCTGAGGCGATCTCCATGGATCCGCAGCAGCGGGTGCTCCTGCAGGTCACCTGGGAGGCGATCGAGCGGGCGGGCATCGTCCCGTCGAGCCTCAAGGGTTCGCAGACCGGCGTGTTCGTCGGGCTGATGCCGAACGAGTACGGGATGCCGCTGTGGAAGTGGCAGGACGAGACGGCCGGTTTCATGGGCACCGGCACCTCACCCAGCGTGGCGTCCGGGCGGATCGCCTACCTCCTGGGCCTGGAAGGTCCCGCCCTGACCATCGACACCGCCTGTTCGTCGTCCGGCGTGGCGATCCACACCGCCGTCCGGTCCCTGCGCAGCGGCGAGACGGACCTGGCGCTCGCGGGCGGCTGCACCGTGCTCACGGGGCCCGGCATGTTCGTGGACTACGCGAAGAAGGGTGCCCTCTCACCGGACGGACGCTGTCGTACCTTCTCCGACACCGCCAACGGAACCGTCTGGGCCGAAGGTGCGGGCGTCCTCGTCCTCGAGCGCCTCTCGGAGGCCCGGCGCAATCGGCGCCGCATCCTCGGCGTCATCAAGGGAACCGCCGTCAATCAGGACGGCGCGAGCAACGGCCTCACCGCACCGAGCGGCAAGGCTCAGGTCAAGGTGATCCAGCAGGCGCTCGCCGACGCCCGGCTCACGCCCGGCGAGATCCAGCTCGTGGAGGCGCACGGTACGGCCACCAAGCTCGGCGATCCCATCGAGGCCAACGCCATTCAGGCCACCTACGGAGCGGACCGCGAGGACGAGCCCGTGTGGATCGGCTCGTTCAAGTCGAACATCGGCCACTCCATGGCCGCCGCGGGAGTCGGCGGTGTCATCAAGTGCCTGAGCGCGATGCGCGCCGGCACCATGCCCAAGACCATGCACGTCGAGGAGCTCAACTCCCACGTGGACTGGTCCTCGTCGGTGAACGTCCTGCGTGAGAGCAGGCCCTGGCCCGCGGCACAGGACGGGGCACGTCGGTGCGCCGTCTCCTCGTTCGGCGTCAGCGGCACCAACTCGCATGTGATCCTGGAGGCCTGGGAGGACGAGCCGACGGCTGTCGCGGCCCCGGCGGACGCCTCCGACGACGCCACGCACGTCCTCACCCTCTCCGCCAAGACGCCGACGGCTCTGCGTTCTCACGCCGCGAGGGTCGCCGAACACATCACCTCCGGGACCTCGTCCCTGGCGGCGACCGCTCATGCGCTCGCGACACAGCGCGAGCACTACGCTCACCGCGCCGTCGCCATCGCGGGAGGACGAGAGGATCTGGCCGCTGCGCTCCAGGCGTTCGCCGACGACACGGACTCCCCGGCAGTGGTGCACGACGAGGCACGTCGCATTCGGCGCCCGGTCTTCGTGTTCCCCGGTCAGGGGTCCCAATGGGAGGCCATGGCCGTGCAGCTCCTCAAGGACTGCGACGTCTTCCGGCTGAGGATCGAGGAGGTCGCGGGAGCCTTCAAGCCCTACCTCGACTACGACTTGCTGGCAGTGCTGACCGGCGAGGACCAGGACACGGACCGAGAGCGCACGGACGTCGTCCAGCCACTCATCTTCACCATGATGCTGGGTCTCGCGTCGATCTGGGAGCTCGCCGGTGTCCGGCCCGCCGCGGTGATCGGACATTCTCAGGGCGAGGTCGCCGCCGCGTGCCTCGCCGGTGCTCTCAGTCTCGATGAGGCGGCCCGTGTGGTCGCCTGCCGCAGCCGCGTTCTGGAGGACGAGGGGCGCGGCGCCATGGTGGCCGTGGCGCTCGGCGTCGAGGAGGCGCTGGCCGCCACACGCGAAGCGGTCGCGGATCTCACGGTCGCGGCGAGCAACGGCCCCGCATTCACCATCCTGTCCGGCGACGACGAACCCGGTATCCGACGTCTGCTGGACCAGTGCGAGGACCGGGGCGTGTACGCCCGCCGGGTCCCGGCCAAGTGCGCCTCGCACTCCCCCGTCATGGCCGAGCTCGAAGGCTCGATCATGGCAGGACTCGACGGCCTCCAGGCCTCCGCGGAGGAGGTGACCTTCTTCTCCACAGTCGAAGGCGGCCGCGTACGGGGGCAGGACCTGACCCCCGCGTACTGGTTCCGGAACCTGCGCGAGCAGGTCCGGTTCGCCGAGACCGTCACGGCCATGGTGTCGCACGGCTACGACGCGTTCATCGAGATCAGCCCGCACCCGGTGCTCCTCACCCCGCTGCGTCAGATTCTGGAGCGGGCCGACAGCGACGCCCCGGTATGCGCGACTCTCCGTCGGGACCAGGGTTCGTACGAGCGGTTCCTGACGGCTGCCGCCGAGGCCTACGTACAGGGACACGACGTCGACTGGGCTGCCCTGCACAGCGGTGCGTGGTCCGCGGGTCCGGCTCCGGAGGGCCTCCCCACCTATCCGTTCCAGGGACGCAGGTTCTGGCTGCCGTCGCAGATGGAGACCACGGTGCAGACCACGGCCGCCCCCGTGGCCGCCGCTGCCCGCCCGAGCGCGCGCAGGACGGGGATCGCGGCCGGCGGCCACCCGTTCCTGGCATCCGTGGTCGAGACGGTCGACGGCACCACGGTGATGAGCGGGCGCCTGTCCATCCGAAGCCACCCGTGGTTGATGGACCACCGGGTGGAGGACACGCCTTTGCTGCCCGGCACCGCCTTCGCGGAGCTGCTGCTGTCGGCGGGACGCGAACTCGACTGCCCCGACCTCGACGAGATGGTGCTCCGGGATCCGCTGTTCCTGCCGGTGGACGGGTCTCAGGTCGACGTCCAGGTGACCGCGCGCAGCGCCGACGCGCAGGGGAAACGGGCCGTGGCGGTGTACTCGCGCTCGGCGGCCGACGCCGAGTGGCGGCATCACGCGGAGGGCTTGGTGTCCCCCGAGACCCCTCGACCGGCTCCCGCCGCTCCCCCGACCGAGGCCGGTGCCGTACGCCTGGAGACCGACACGCTGTACTCGCGGCTGCACGGGATGGGCTACGGCTACGGCGACGCGTTCCAGGGCGTACGCAGTGGAGAGCACGGCGACGGCTGGGCCCGCTCCCGGGTGGTCCTGCCGGACAGCGCTCGGGTCAACCACAGCGGCTTCGCGCTGCACCCGGCGCTGTCCGACGCGGCACTGCACGCCGCCGTGGCCTGTGGCCTGATCGAAACGCCGGCGGCAGCGGACATCGCCGTCCCCTTCGCGTTCAACGGCGTACATGTCGATGAGGGCGACCATGCCGACCAGTGCTGGGCCGTTGCCCGCCGAGTGGCTCCCGACGCGATCGCCCTCACTCTGGCCGACGACGACGGACACGTGCTGCTGAGCATCGACCGCATGGTGGTCCGCGGCCTTGAACGACCCGCTCAGCAGCCGGACCACGAGGAGGCCACGCTCTACACGACCGACTGGGCCGAGGCCGAGGGCGAACTCGGCGTGGAACGCCGCCTGTGCGTCGTGGGGGCTGACGGGCCGCTCGCCTCGTCCCTGCGGGACACCGCACACGGCGGGATCACCGTGGCCACGCTCGACGAGGCCATCATGATCGTCAGGGCTCTGCCCGGAGACTGGCAGGTCGTCCTGTCCGCCCCGCCGACGGGCCCCGGGGCCGTGACCGCGGCTCACGTCCACGACTCGGCAGCGTGGGCGCTGGAGGCCGTCCAGCAGTGGATGCTCGCCGAGGACCTCTCCGAGCGTGCCCTGCTCACGTTCGTCACCCGGAACGCGGTGGCCGTGCCCGGCGATGACGCGCACGACCTGGCCTCCAGCACTCTCTGGGGGATGGTGCGCACCACGCAGACCGAGAACCCCGGTCAGATCCGCATCATCGACGTCGACGACGCCGCAGTCGCCGAACCGGCACCGATCAAGGCGGCGTTGCTGCGTTCCGAGGCCCAGCTGGCCGTGCGCGCGGGCCGTGTGCTGCGCCCGCATCTGTCGCCTCACGCTTCCGTCACCGCCCCGTTCCCGGACTGCGGCGACGACACCGTCGTCATCACCGGCGGCACCGGCACCATCGGCCGCGCCCTGGCCCGCCACCTCGTCACCCGGAAGTCCGTGCGGTCTGTGGCGCTGCTCAGCCGCAGTGGCCGGCAGGCGCCCGGTGTCACGGCCCTCACCTCCGACCTGGAGCGGCTGGGCGCCTCGGTTCGCGTGCTCGAGGTCGACACCACCGACGCGGAGCGCCTGCAAACGGTCCTGGACCAACTGCGCTCGGAACGTCCGCTGGCAGGCGTCGTCCATGCCGCGGGCCTCCTCGACGATGCCATCGTGCCGAACATGACGCCCGGGCAACTGCACCGTGTGCTGGCGAGCAAGGTCGACTCGGCGCTCAACCTGGACGCTGCGACGCGCGAGGACGACCTTCGCTTCTTCACCGTCTTTTCCTCCCTCTACGGCGTGCTCGGCGGCCCCGGGCAGGCCAACTACGCCGCCGCGAACACCTTCCTGGACCACTTCGCGCACTGGCGCCGGGCACAGGGGCGGCCGGCCAACTCCGTGGCCTGGGGCCTGTGGGACGAGGCGACGGGCATGACGGGGCACCTCGACGAGGCAGATCTGCTGCGGCTGCGGCGCAACGGAGTGGCGCCGTTCACGGTGCCGGAGGGACTCGCCCTGTTCGATGCCGCACTCGGCAGCGGCACCACCGCGGTGATCGCGGCACGTCTCGCGGTGGCCGATGCGACCGACGACGCGACGATGGACGGCCCGTTCCTGTTCTCCCGCCTCGCCGGGCGCGCAGTGCCCCGGACCGAGAAGGTGCGCGAACCCGCACCCGCACCCGCTGTCGCCGCCGCCCCGCCCGCGCCGGCTCCGCGGCCGGAGACGCAGGAGGAGCCTGCCGCCTCCGCTCAGCCACGCGCCGAGGCCGACCGGCCCACCCGTCCGCAGGAGGCGGCCACCGTCCTCGACCTCCTGAACTCGACGGACGCATCCCGCGACCAACGCGTCGCCGGCCTCCTCACGGTGGTCAAGGAGAGCGTGGCCGAACTGCTCGGCACCGAAGCCCGGCGCGTGGATGCCCAGCAGTCCTTCTACGAGATGGGCTTCGACTCCCTCACCTCCATGGAGCTGCGCGTCCGCCTCGGCCGCAAACTCGACATCCGGCTGGGCGCCACCGTGGTCTTCGACCACCCGACTCCGGAGGCACTCGTCTCCCACGTCGTGGATCTGTTCCAGCCCGATGACGGGCAGGAGCAGCCGGACGAATCCGAGGAGCCCGGCCCGGGCCAGGTCGCCGAGACGGGCTCCGCTCCGGCCCCGACTGCCGTGCCGACGAAGCAGCAGGCGCGACAGAGCGCGGACGCCGAGGAGCCGAGGGCGGACGAGCCCGCCCTACCCGACTCCGCCCCGTTTCCCCTGACCAAGCTGCAGGAGGCGTATCTCGCGGGGCGCTCCGGCGACTTCGAACTGGGCAATGTCTCCACGTACTTGTACGTGGAGGTCGACCTGACGGGCTTCGACGTGGCGGCGGCCGAGCACGCGCTCGACCGGCTCGTACGGCGCCACCCGATGCTGCGGGCCGTCTTCGACCCGGAGGCCGGGAGCCAGCGGGTGCTGGGCACCGTGCCGCGCGTATCGATCCCCGTCGAGAACCTGACCCGGCTCACGGAGGACGAGCGCGACGAGCGGCTCGCCGCGATACACGCGGAGCTGAAGGCCAAGGAGTTCGACGTCACGAGCTGGCCCCTGTTCATGGTGCGCGCCACGGCCATCAGCCCGACCGTGACGCGACTGCACTTCGGCATCGACGTACTCGTCTCGGACGGCAGCAGCACCTCCGTCCTCTTCAAGGAGTGGGCGCAGCTGTACGACGCTCCGGACCTGCAGCTTCCGGAACTCCGGTCCGGGTTCGACGAGTTCACGCTCAAGGTGCGCGAGCAGGCCGCGGCGGCGGAGAACAGCCGGAGCAGGTCGTACTGGAGCGGTCGCCTCCAGAGCCTGCCCCCCGCTCCTGAACTGCCCCTCGCGGTCCGCCTTGCCGATGTGCCGCGCCCCGTGTTCACCAACCGCTTCCTACGCGTCGACGCGCCGGAGTGGGAACAGTTCAAGCGCAATGCCGCGGCAGCCGGTCTGACGGCGTCGGGCGCCGTACTCGGGGCGTACTGTCACGTGCTGGCCGCGTGGTCCAAGACACCGGACTTCACGATCACCTGCCTCGTGTCGCAACGGGACGCGGTACCCGGTGTGGACACAGCGCATGTCATAGGCAACTTCTCCTCCACAAGTCTGCTCGAGGTGCGGGTCGACCAGGCCGCTCCTTTCCGGGACACGGCCCGTCGGATCCAGCGGCAGCTGATGCAGGACATGGAACACACCGACTATTCGGGCCTCGATGTGCTGAGGGACCTCGGTCGCATGGACGCGAGCGCGGGGCGGGCACGCATGCCGGTCGTCTTCAACAGCACGATCGGCGGGGCCGCCGCGGGCGGGCAGGAGGCCGGGCCCGTGGGCTGGCTGTGCCGCATGGGCGAGACCGGCACGCCCGTATGGAGCGGGGTCCGCACCCCGCAAGTCATCCTCGACCACACAGCGTTCGAGGAGAGCGGTGGTCTGATCCTCAACTGGGACGTGGTGGAGGAAGTGTTCCCGGAGGGCGTCTTGGACTCCATGTTCTCGGCATACGAAAGGCTGATTCGTGAACTCTGTCGCTAA	MACRYPGGMNTPERLWALVDEGRDVITDFPDNREWHTEDLYDPSFVRQGGFLHDADLFDADFFGIRPAEAISMDPQQRVLLQVTWEAIERAGIVPSSLKGSQTGVFVGLMPNEYGMPLWKWQDETAGFMGTGTSPSVASGRIAYLLGLEGPALTIDTACSSSGVAIHTAVRSLRSGETDLALAGGCTVLTGPGMFVDYAKKGALSPDGRCRTFSDTANGTVWAEGAGVLVLERLSEARRNRRRILGVIKGTAVNQDGASNGLTAPSGKAQVKVIQQALADARLTPGEIQLVEAHGTATKLGDPIEANAIQATYGADREDEPVWIGSFKSNIGHSMAAAGVGGVIKCLSAMRAGTMPKTMHVEELNSHVDWSSSVNVLRESRPWPAAQDGARRCAVSSFGVSGTNSHVILEAWEDEPTAVAAPADASDDATHVLTLSAKTPTALRSHAARVAEHITSGTSSLAATAHALATQREHYAHRAVAIAGGREDLAAALQAFADDTDSPAVVHDEARRIRRPVFVFPGQGSQWEAMAVQLLKDCDVFRLRIEEVAGAFKPYLDYDLLAVLTGEDQDTDRERTDVVQPLIFTMMLGLASIWELAGVRPAAVIGHSQGEVAAACLAGALSLDEAARVVACRSRVLEDEGRGAMVAVALGVEEALAATREAVADLTVAASNGPAFTILSGDDEPGIRRLLDQCEDRGVYARRVPAKCASHSPVMAELEGSIMAGLDGLQASAEEVTFFSTVEGGRVRGQDLTPAYWFRNLREQVRFAETVTAMVSHGYDAFIEISPHPVLLTPLRQILERADSDAPVCATLRRDQGSYERFLTAAAEAYVQGHDVDWAALHSGAWSAGPAPEGLPTYPFQGRRFWLPSQMETTVQTTAAPVAAAARPSARRTGIAAGGHPFLASVVETVDGTTVMSGRLSIRSHPWLMDHRVEDTPLLPGTAFAELLLSAGRELDCPDLDEMVLRDPLFLPVDGSQVDVQVTARSADAQGKRAVAVYSRSAADAEWRHHAEGLVSPETPRPAPAAPPTEAGAVRLETDTLYSRLHGMGYGYGDAFQGVRSGEHGDGWARSRVVLPDSARVNHSGFALHPALSDAALHAAVACGLIETPAAADIAVPFAFNGVHVDEGDHADQCWAVARRVAPDAIALTLADDDGHVLLSIDRMVVRGLERPAQQPDHEEATLYTTDWAEAEGELGVERRLCVVGADGPLASSLRDTAHGGITVATLDEAIMIVRALPGDWQVVLSAPPTGPGAVTAAHVHDSAAWALEAVQQWMLAEDLSERALLTFVTRNAVAVPGDDAHDLASSTLWGMVRTTQTENPGQIRIIDVDDAAVAEPAPIKAALLRSEAQLAVRAGRVLRPHLSPHASVTAPFPDCGDDTVVITGGTGTIGRALARHLVTRKSVRSVALLSRSGRQAPGVTALTSDLERLGASVRVLEVDTTDAERLQTVLDQLRSERPLAGVVHAAGLLDDAIVPNMTPGQLHRVLASKVDSALNLDAATREDDLRFFTVFSSLYGVLGGPGQANYAAANTFLDHFAHWRRAQGRPANSVAWGLWDEATGMTGHLDEADLLRLRRNGVAPFTVPEGLALFDAALGSGTTAVIAARLAVADATDDATMDGPFLFSRLAGRAVPRTEKVREPAPAPAVAAAPPAPAPRPETQEEPAASAQPRAEADRPTRPQEAATVLDLLNSTDASRDQRVAGLLTVVKESVAELLGTEARRVDAQQSFYEMGFDSLTSMELRVRLGRKLDIRLGATVVFDHPTPEALVSHVVDLFQPDDGQEQPDESEEPGPGQVAETGSAPAPTAVPTKQQARQSADAEEPRADEPALPDSAPFPLTKLQEAYLAGRSGDFELGNVSTYLYVEVDLTGFDVAAAEHALDRLVRRHPMLRAVFDPEAGSQRVLGTVPRVSIPVENLTRLTEDERDERLAAIHAELKAKEFDVTSWPLFMVRATAISPTVTRLHFGIDVLVSDGSSTSVLFKEWAQLYDAPDLQLPELRSGFDEFTLKVREQAAAAENSRSRSYWSGRLQSLPPAPELPLAVRLADVPRPVFTNRFLRVDAPEWEQFKRNAAAAGLTASGAVLGAYCHVLAAWSKTPDFTITCLVSQRDAVPGVDTAHVIGNFSSTSLLEVRVDQAAPFRDTARRIQRQLMQDMEHTDYSGLDVLRDLGRMDASAGRARMPVVFNSTIGGAAAGGQEAGPVGWLCRMGETGTPVWSGVRTPQVILDHTAFEESGGLILNWDVVEEVFPEGVLDSMFSAYERLIRELCR	MPTYRGGRHEHGQNFLTDHTTIDRLSRLVGDSTGPIVEIGPGQGRLTRELQKLGRSLTAVEIDSRLADRLASASQFREQKHVTVVNADFLHWPLPTTPYVVVGNVPFHLTTAILRRLLHDGAWTQVVLLVQWEVARRRAGIGGSSMMTAQWWPWIDFSLHGRVPRSAFKPAPSVDGGLLEMTRRPDPLLSPDARESYRQFVHDVFTSRGRGIGEILANVSSSLGKRGALQLLKSEGIRSSSLPKDLSAEQWARLFTSASPTKSAKTGRNAHPAHSARRQGR	807.12	gnl|BL_ORD_ID|818|hsp_num:0	888			117	240	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0001236.1|Thiotetroamide_4 # 9987 # 12134 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.711	BGC0001236.1|Thiotetroamide_4 	9987	12134	-	Loose	750	69.3218	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	27.7	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGACCGCACTGACACACCAGCCACAACCGGCACCGCCGTACACGGCACCAGGCGCGGCCCCCGTGGCTGTCATCGGTTTGTCGTGCCGCTTTCCCGGCGCCGCCGATCCGGGCGCGTTCTGGCGCAACCTCGTGTCCGCGGCGGACAGCGTGGGCACCGCTCCGCCCGGTCGCTGGGAGGAACGGGTCGGACCCGCGCCCGCGGAACCCCGCAACCCCATTCGGCATGGCGGCTTCATCGAGGGCATCGACGAGTTCGACGCCAGGTTCTTCGGCATCGTCCGGCGTGAGGCCGAGTACATGGATCCGCAGCAGCGGCTCCTGCTCGAGCTCTCCTGGCAGGCGTTGGAGGACGCCGCCGTTCCCGCTCACAGCCTGCGCGCGACGCGCTGGGGCGTCTATGTGGGGGCGGGCGCCGATGACTTCAGAACGCAGTACTTCGCCTCCGGGCGCCTCGACAGGTTCGGGCACATGGGCTCGAGCCGCTCGCTGCTGGCGGGGCGCGTCTCCCATCACCTCGGGCTGCGCGGCCCCAGCGAAGTCGTCGACACCGGTCAGTCGTCCTCCCTGTACGCGCTGCACCGGGCACTCGCGAGCCTGCGGCTGGGCGAATGCGACGCGGCGCTCGTCGCCGGCGTGAACCTCAACCTCCTGCCGGACGTCACCGACCAGGTTCAGCTGTGGGGCGGCCTGTCCGCCGACGGCCGCTGTCGCGCCTTCGACGAGCGTGCCGACGGATACGTCCGCGCCGAAGGGGGTGGCGTCGTCGTACTCAAGCCGCTCGAGGCTGCCGTACGCGACGGTGACCACGTCTACTGCGTGGTGCGCGGCAGTGCCGCCAACAACGACGGAGGCAGAACAGCTCTCGGCGTCCCCAGTCCGGACGCCCAGCGCGAGGTGATCGAAGCCGCCCACCGCGCCGCGGGGGTCACGGGTGCGTCGGTCGGCTACGTCGAACTGCACGGTACGGGAACGCCCGTGGGTGACCCGGTCGAGGCCGAGGCCCTCGGCGAGGCCATCGGCAGGCGGCGCTCGCGGGCCACGCCGTTGCTCGTGGGCTCGGTCAAGTCGAACATCGGGCACCTGGAGTCGGCGGCGGGCATCGCCGGATTCATCAAGGCATGCCTGGTACTGCATCACGGGCAGCTGCCGCCGACCCTCCACCATCACCGCAGCCCGGCGGAACTGCCGTTGGCGGACCTCAACCTCCGGGTCGTCGGTGCGGACCAGGAAGAGCGCCTGGGCACCGACGAAGTCGTCGGGGTCAGCTCCTTCGGCATGGGCGGCACCAACGTCCATGTGGTCCTGGCGGGTTCACCAGCCAGGACGGATCCGTCCGGCCGACTCGGGTCCCGGACTCCGTCCGAGCGCCCCACCACGGACACCGTGTGGTGTCTCTCCGGTCGCACCCGCGAAGCGGCCCGCTCACTGGCCCGCGCCTTCCTCGAACACTCCTTCCCCACGGAGCGCTACACCGTGAGCGACGTGGCGTGGTCCCTCGCCCAGCGCGGCGAGGGCGAGCACCGGGTCGCGGTGGTCGGCGGCAGCTGGGACGAGATGCGCGACGGACTGCTCAAGATCGTGGCAGGCCACGACCTGGCCATCCCGGCGGACTGGCTGCACGAGGGAGGGACTGAACGCGCTGCCTGGGTCGCCGTCGCCGGTACCTACGCCGCCCACGGAGACCTGGCCAAGGTCGCAGATCGATTGGGAACAGGACGGCGCAAGGTGCCCGGCCTGCCCACGTACCCCTTCGAACGCGACACCTTTCACGGGCCCACCCCGCCCCACCCCGTCGCCCCGGCCCCCGAACCGGCCCCCGCGGCACCGGAAGAGGCCCGCACCCGCCCCCTGCTCGACGGCTGGCAGCAGGCTGCCGATCCTTCGGAACGGCTCTGGCTCATCCGGTCGTTCCTGGAGCGCGAACTGCTCGACGTTCTGGGCGAGACGGGCGACGAGCACCTGCGCGTGGACCCCGACAGCACCTTCAAGGACCTGGGCGTCGACTCCATGTCCCTGCTCGAGCTCCAGGACCGTCTCACGGCCGCCACCGCAGTGGAACTCCCCGAGTCCGCGCTCTTCGACCACCCGACGGTCAACGACCTCGCGGCACATCTGAACACCGAACTGGAGGCACTCCGTGGCTGA	MTALTHQPQPAPPYTAPGAAPVAVIGLSCRFPGAADPGAFWRNLVSAADSVGTAPPGRWEERVGPAPAEPRNPIRHGGFIEGIDEFDARFFGIVRREAEYMDPQQRLLLELSWQALEDAAVPAHSLRATRWGVYVGAGADDFRTQYFASGRLDRFGHMGSSRSLLAGRVSHHLGLRGPSEVVDTGQSSSLYALHRALASLRLGECDAALVAGVNLNLLPDVTDQVQLWGGLSADGRCRAFDERADGYVRAEGGGVVVLKPLEAAVRDGDHVYCVVRGSAANNDGGRTALGVPSPDAQREVIEAAHRAAGVTGASVGYVELHGTGTPVGDPVEAEALGEAIGRRRSRATPLLVGSVKSNIGHLESAAGIAGFIKACLVLHHGQLPPTLHHHRSPAELPLADLNLRVVGADQEERLGTDEVVGVSSFGMGGTNVHVVLAGSPARTDPSGRLGSRTPSERPTTDTVWCLSGRTREAARSLARAFLEHSFPTERYTVSDVAWSLAQRGEGEHRVAVVGGSWDEMRDGLLKIVAGHDLAIPADWLHEGGTERAAWVAVAGTYAAHGDLAKVADRLGTGRRKVPGLPTYPFERDTFHGPTPPHPVAPAPEPAPAAPEEARTRPLLDGWQQAADPSERLWLIRSFLERELLDVLGETGDEHLRVDPDSTFKDLGVDSMSLLELQDRLTAATAVELPESALFDHPTVNDLAAHLNTELEALRG	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	171.88	gnl|BL_ORD_ID|1968|hsp_num:0	1943			450	1239	isoniazid
BGC0001236.1|Thiotetroamide_6 # 13516 # 14649 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.718	BGC0001236.1|Thiotetroamide_6 	13516	14649	-	Loose	750	326.635	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	48.41	3003463	protein variant model	G387D	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGCGAGACGGCGCCAACGGAATCAGCTGCCTGGAGGACGAATGGGCCCGGGAGCTGCCCGTCCGGATCGCCGGGCGCCTTGCGGTGAACCCCGCCGACTCCCTGGCACGGACCGAAGCCCGTCGGCTCGACCGTGCGGAGCAGATCGCCCTCGTGGCGTCCCGGGAGGCCTGGCAGGACGCCGGCTCCCCGGAACTTCCCCCTGAGCGCCTCGCGGTGGTGATGGGCACCGGCATCGGTGGCGTCACGTCCCTGCTGGCCCAGAACCACACGCTCGAGGTCAAGGGGCCGCGGCGGGTCTCACCCCACACCGTGCCCATGCTGATGGCCAACGGCCCCGCTGCGTGGGTCAGCATGGACCTGGGCGCACAAGCCGGCGCCCACACTCCCGTCAGCGCTTGCGCGTCGGGGGCCGAGGCCATCGCTCTCGGCCTGGACCTCATCCGGGCCGGCCGGGCCGATGTCGTCGTGGCCGGGGGCGTGGAAGCCAGCGTGTTGCCCCTGCCGCTCACCGGCTTCGCGCAGATGATGGCGCTGTCCACGTCCAACGATGATCCGGCACACGCCAGCCGGCCCTTCGACGCCCAGCGCAATGGCTTCGTCCTTGCCGAGGGGGGCGCGGTCGTCGTGCTGGAGCGAGCGGACCACGCGCGAGCCCGCGCCGCTCGCGCCCATGCGACGGCCCTGGGTGCGGGCACCAGTTCGAGTGCCGCCCACATCACCGCCTCGGACGTGGCAGGACAGGTGCGCGCCATGACCCTGTCGCTGCGCGACGCGCGGATCACCGGGGAGGACGTGGGGCACGTCCACGCCCACGCGACGTCGACACCTCAGGGCGACGCGTGCGAATCCGATGCCATCGCCCAGGCCATCGGTACGCATGCCGTGGTCACCGCGACGAAATCCATGACCGGCCACATGTTGGGGGCGTCCGGGGCCATGGGTGCGGCTGCGGCGGTCCTGGCGCTGCGTGACGGCGTCGTGCCCGCGACCCGCAACCTGCGGGAAGTGGATCCGCGCATCGATCTGGATGTGGTGATGGACGAGCCACGCCCGGGACGGTTCCACACCGCATTGGCCAACTCCTTCGGCTTCGGCGGGCACAACGTCTCGCTCGTCTTCGGCCGTGCCTGA	MRDGANGISCLEDEWARELPVRIAGRLAVNPADSLARTEARRLDRAEQIALVASREAWQDAGSPELPPERLAVVMGTGIGGVTSLLAQNHTLEVKGPRRVSPHTVPMLMANGPAAWVSMDLGAQAGAHTPVSACASGAEAIALGLDLIRAGRADVVVAGGVEASVLPLPLTGFAQMMALSTSNDDPAHASRPFDAQRNGFVLAEGGAVVVLERADHARARAARAHATALGAGTSSSAAHITASDVAGQVRAMTLSLRDARITGEDVGHVHAHATSTPQGDACESDAIAQAIGTHAVVTATKSMTGHMLGASGAMGAAAAVLALRDGVVPATRNLREVDPRIDLDVVMDEPRPGRFHTALANSFGFGGHNVSLVFGRA	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	90.62	gnl|BL_ORD_ID|1968|hsp_num:0	1943			114	1245	isoniazid
BGC0001236.1|Thiotetroamide_7 # 15242 # 17665 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.700	BGC0001236.1|Thiotetroamide_7 	15242	17665	+	Loose	200	28.4906	Pseudomonas aeruginosa soxR	37.5	3004107	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCCGACTACGTCAAAGGGCAGGCCGAGCGAGCCGGCGCGACTGTGCTGAGCGCCACGGCATCGGCGGCGGAGCGCTCGTTCCCGCTGGGCGTCGTTGCCCAACTCCTGTCCTGTCTGGGCTATTCCATGGACGAGATCGCGGCCGCGTGCGAGTCACCGGCCAAAGTGGCCGCCGTGGTGCACGACGCCGTCTGCGAGGTCGCCGAGCGCACACCACTGATCGTCACCGTTGATGATGTCCACGACATCGACAGCGAGTCCCTGCGCTACCTGCTCTACGTCATCCACCGTGTGGCCCCACTGCGCGCCCTCATCCTGCTCACCGGGAGTTCCGACCTCCCCCAGCAGAGTCCCGCATTGACGGCCGAGTACATGCGCAATCCCAGCTGCTCGCTGCTGCGCCTCACCTCGCTGTGCCCTGCGTGTGTCAAGGGAGTACTCGCCGAGCACATGGGAAGCGGCGTCTGCGACCGGACCGTGTCGCTGTGGCGGCGGGCGTCCGGGGGGAGCCCTCTGCTGCTGCACGCGCTTCTGAAGGACTGGTCGAGTTCCGGTGCACCGGGCGAACCGGGCCAGGGCGCGGTCCCCCCTCCACCGGGTGGCGACGCGGTCCGGTTCGCCGTTCAGTACATCCACGGTCTGATGACCGAGGACGGGCTGCGGACCGCGCGGGCGCTCGCTGTCCTCGGGGAGTCGGCTACCGCGGAGCGAGTGGAGCGACTGCTGCACCACCTGGGCATGTCCGCCGGTGAGGCCGCACGTTCGCGCACGGCCCTGGAGGCAGCCGGCCTGACCGACGGCCTCACCTACCACCTGGAGGCAGCTCGTGACGTGGTGCTGGACGGCATCCCCGGCGACGAACGCACACGGCTGCATCTGAACGCCGCCCTGGCACTGCGCGAGGCCAACGCCGAACTGGGCGTGGTGGCAGGACATTTGGTGCAGGCGCGGCCCGCCCAGGAGCCCTGGGCGGTCATCGCCCTGCGGGAAGCTGCCGCGCAGGCCCTGCATGAGCACGACGCCGAACAGGCCATCGCCTTCCTCAGAGCCGCGTACGACGCGTCCGCCGACGGATCGACGCGCGCCCTGGTCCGGGCCGAACTGGCGCAGGCGGAGTGGGAAGTGGACCCGGGGGCAGTGCGCTGGCACCTGACCGATCTGCTCGATGAGCACCGGGCCGGTCGACTGAGCCGGGATCACAGTCTGCTGCTGGGCATGTATCTGTTGTGGTCGGGGCGGACGCAGGAGGTCAGCGCCCTCCTCACCGACCTCGATGCCGTGCGGGAGGAGCTGCCCCAGGACGCTCGGGCCCGCCTGGACGCCTTGCGGGTCTGGCTCGCGTACTTCTTTCCCAACCACGGCGCGCGATACCGGCACAGCCCCCTGGAATCCCCGCACGATCCGGGCCAGTGCATCGTGTCGGTCGATCCGCAGTGGGACGGAGCGCTGGTGCTCGCGTCGTTGCTGACCGAGGGACCCACCGACGACGCGTGTGGAGCCGCCGAGCAGCTCCTGCAGGCGCAAGTGCCGCATGAACCACTCCTGGCACCCACGATGGCCGCGTTGATCTCGCTGATTCGCGCCGCACGCCTCGAACGAGCCGCGGACTGGTGCGACCGGCTGGTCGTGGGCTGCTCGGGGCGCACGACCACCTGTCAGGCCATCCTGCTGGCCGCCAGCGCCATCCTGGAGAGCTGGCTGGGCAATTTCACGACCGCGCTGAGCCGCGCGGAGCAGGCCCTGGCGCTGCTGCCTCCACCGGCTTGGGGGGTGGCCGTCGGTCTGCCGCTCTCCGCCAAGGTTCTCGCCTGCGTCGGTCTCGGGGACCTCGAGGCGGCGACCGAGTGCTTCCGCGCCCCGGTACCCCAGTTGATGTTCCAGTCCCTGCCCGGACTGCACTACTTGCAGGCGCGCGGTCGTCTCCACCTGGCCGCGGGGCGTCACAAAGCGGCGCTCGGCGATTTCTACGCGTGCCGGGACCTGATGGCCGCATGGAAGCTCAAGGTGTCCGTCTTCACGGCGTGGCGGGTCTACGCCGCCGAAGCGCTCGCCGAGCTCGGTGACAGGGACGAGGCGGCGCGCCTCCTGGAGGAGGAGCTGGCACAGCCGGACACGGGCAGCCCGTGGCTGCGCAAGCAGGCGCAGGTGGTGTACGACCGGTTGGGTGGCACCGGCTCCGACACGCGGTCCGGCATGAGGCCGTCGGCGGTGACCGAAGAGTTCCACACGCTGAGCAGGGCCGAACATCGGGTGGCCCAGCTCGCGCGGGAGGGTCTCACCAATCGGGAGATCTCCGAGCAGCTCGGTGTCACCCCCAGCACCGTCGAGCAGCATCTGACCCGCATCTACCGGAAGCTGGGGGTGCGGGGCCGTGCAGAGCTCCCCGTGGCACTGAACTCAGCGGAGTTCTGCCGGAGTTGA	MADYVKGQAERAGATVLSATASAAERSFPLGVVAQLLSCLGYSMDEIAAACESPAKVAAVVHDAVCEVAERTPLIVTVDDVHDIDSESLRYLLYVIHRVAPLRALILLTGSSDLPQQSPALTAEYMRNPSCSLLRLTSLCPACVKGVLAEHMGSGVCDRTVSLWRRASGGSPLLLHALLKDWSSSGAPGEPGQGAVPPPPGGDAVRFAVQYIHGLMTEDGLRTARALAVLGESATAERVERLLHHLGMSAGEAARSRTALEAAGLTDGLTYHLEAARDVVLDGIPGDERTRLHLNAALALREANAELGVVAGHLVQARPAQEPWAVIALREAAAQALHEHDAEQAIAFLRAAYDASADGSTRALVRAELAQAEWEVDPGAVRWHLTDLLDEHRAGRLSRDHSLLLGMYLLWSGRTQEVSALLTDLDAVREELPQDARARLDALRVWLAYFFPNHGARYRHSPLESPHDPGQCIVSVDPQWDGALVLASLLTEGPTDDACGAAEQLLQAQVPHEPLLAPTMAALISLIRAARLERAADWCDRLVVGCSGRTTTCQAILLAASAILESWLGNFTTALSRAEQALALLPPPAWGVAVGLPLSAKVLACVGLGDLEAATECFRAPVPQLMFQSLPGLHYLQARGRLHLAAGRHKAALGDFYACRDLMAAWKLKVSVFTAWRVYAAEALAELGDRDEAARLLEEELAQPDTGSPWLRKQAQVVYDRLGGTGSDTRSGMRPSAVTEEFHTLSRAEHRVAQLAREGLTNREISEQLGVTPSTVEQHLTRIYRKLGVRGRAELPVALNSAEFCRS	MKNSCASRELSVGELARRAGVAVSALHFYETKGLISSQRNAGNQRRFSRETLRRVVVIKVAQRVGIPLAEIARALQTLPAGRSPSAADWARLSAQWKEDLTERIDKLLLLRDQLDGCIGCGCLSLQACPLRNPGDQLSAEGPGAHWLDAEGREHDG	517.31	gnl|BL_ORD_ID|2395|hsp_num:0	2775			321	462	tigecycline; ciprofloxacin; acriflavine; tetracycline; rifampin; chloramphenicol; ampicillin; norfloxacin; cefalotin; triclosan
BGC0001236.1|Thiotetroamide_8 # 17674 # 19440 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.701	BGC0001236.1|Thiotetroamide_8 	17674	19440	-	Loose	700	27.7202	vanS gene in vanF cluster	36.17	3002936	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	ATGACAACCAGAGGAATGGACGTGCAGGACACAGTGGAACCCGGCCGGGCCGTCGGAGTCGTGGGACTCGGGACGGTAGGCGAAGCGTTGTTGGGCATGGTCGCCGCCACCGGACGCCCGGTGGTCGGCGTCGACCACGACCCCGATGTCATCGCCCGGGTCGAACGACGCCTCAAGGGCCAAGACCTCGACGCGACCGGAGAGCCCGCCTCCTGCGCCCTGACCACCGACATCACCGCGCTGGCCCACGTCGGGGTCGTGGTGGAGGCGGTGACCGATGATCTGGCCGCCAAGCGCGACGTACTTCGCCGGCTGCGTCAGGTCTGCCCGCCCGATACGGCGTTCGTCACCACGGCCTCCTCGCTGCCTCTCTTCCCTCTCGCCACCGCATCGGGGTGTCCCGACCGGATCGCCGGCCTGCGGCTGCTGCGCCCGCCGGCGACCGGCAGGCGCGCCGAAGTCGTACGCACCTCACTGACCTCCGACGAAGCAGTCGAGGTGGCGGAACGCCTCGCGACAGCCATCGGCCTCGAAAGCGTCGTTCTCGGGCACCATGCGAGCGACTCCGCCGCTCGGCTCGTCCACCCGTACCTCAACCGCGCTGCCGCCATGGTCGCGGAGGGTTTCGCTTCCCCCCGCGACATCGATACCGCGATGCGGCTCGGTTGCGGACTGCCGTCCGGTCCGTTGGAGCTGATCGACGAGCTGGGCGTGGACGAGGTCCACAGCTGCCTGCAGTCGCACTGGAACCGCACCGGTGACGAAGCCTTCCGCCCGGTGCCGCTCCTGACCTCGATGCTTCGAAGGGGCACCCTGGGAAGGAAGACCGGCCAGGGCTTCCACGGTTACGACGAGCAAGGTCTGCCGAGCGAGCAGAGCCCGGTCGAGCAGGGCCGTGTGGATTCCCCGTCACCCGGCAGGCGCATACGTCACGTCGGCGTGTACGGCTCCGGCACGATGGCACGCGGTATCGCGGAGGTGTGCGCCACGTCCGGGCTCCGCGTCACGCTGGTGGCTCGTAGCACCGACAAGGCACAGAGCACCGCGATGGCCATCGAGGCATCGCTGGTCAAGGCGGTGCGTCGGGGCAGGATCACTCCGACCGGGAAGGAGGAGGCGGTCGCCGCGCTCGCCGCCGTCGACGACGTGTCGGCGCTCGCCGACTGCGACCTGGTCATCGAGGCCGTCGCGGAGGACCTCGACATCAAGCGCGGCGTGTTCGCGCAGCTCGGGGCGGTTCGCCGGCCCGGTGCGATCCTGGCCACCACTACCTCCAGCCTGTCCGTCGCGGCCTGTACCGCTCCGGCCGGCTGTCCCGGAGAGACGCTCGGCCTGCACTTCTTCAACCCCGCGCCCGTGATGAAGCTGGTGGAGCTGGTGCGGACGCCGGACACGGCCGACGACGTGATGGATGCGGGCCGCGCGTTCTGTGCCGGCCTCGGCAAGGTCTCGGTGACCTGCCCCGACCGAGCCGGCTTCATCGTCAATCGCCTGCTCTTCCCCTATCTCACGGACGCGGTGCGGTTGTTGGATGACCCCGCTGTCGACGTCGGGGCGCTCGACACCGCGGTGGAACGGGGATTCGGATACCCGATGGGACCGTTCACCCTGCTCGACGCCATCGGCCTGGACGTCTCCCTGGCGATCCTGGAACGTCTGCACGCCGAGTTTCCCGGGGCGGGCTGCGAACCCCCGGCCGTTCTCAGGGAGCTGGTGGGCGGGGGCTATCTCGGACGCAAGGCGGGCCGGGGACTGCGCAGGGCGTGA	MTTRGMDVQDTVEPGRAVGVVGLGTVGEALLGMVAATGRPVVGVDHDPDVIARVERRLKGQDLDATGEPASCALTTDITALAHVGVVVEAVTDDLAAKRDVLRRLRQVCPPDTAFVTTASSLPLFPLATASGCPDRIAGLRLLRPPATGRRAEVVRTSLTSDEAVEVAERLATAIGLESVVLGHHASDSAARLVHPYLNRAAAMVAEGFASPRDIDTAMRLGCGLPSGPLELIDELGVDEVHSCLQSHWNRTGDEAFRPVPLLTSMLRRGTLGRKTGQGFHGYDEQGLPSEQSPVEQGRVDSPSPGRRIRHVGVYGSGTMARGIAEVCATSGLRVTLVARSTDKAQSTAMAIEASLVKAVRRGRITPTGKEEAVAALAAVDDVSALADCDLVIEAVAEDLDIKRGVFAQLGAVRRPGAILATTTSSLSVAACTAPAGCPGETLGLHFFNPAPVMKLVELVRTPDTADDVMDAGRAFCAGLGKVSVTCPDRAGFIVNRLLFPYLTDAVRLLDDPAVDVGALDTAVERGFGYPMGPFTLLDAIGLDVSLAILERLHAEFPGAGCEPPAVLRELVGGGYLGRKAGRGLRRA	MGKILRGFRSKMIILLGLSMLLSSAITYLLFKVLQLYYYTSVDYGDTLAYFRKIIQNIGDFNVFLLLFILLSILFFFLLTKPYSAYFNEISKGIHYLAQGDFKHRVQILSNDEFSDIAQSINLASEKLEQAIERGDFSESSKEQLVVNLAHDLRTPLTSVLGYLDLILKDDNLTENQIRHYLTIAFTKSQRLERLIDELFEITRMNYGMLPIKKKQIDLSELLIQLKEELYPVFEKNDLIARMNITSPLSIMGDGELLARVFENLLINANRYGYEGQYVDINGFIDSEEVVIQVINYGDAIPPDELPHIFDMLFTGDKARTHQENSTGLGLFIAENIVEQHNGTITAESDLIRTIFEVRLPMADS	161.10	gnl|BL_ORD_ID|4686|hsp_num:0	1920			312	450	vancomycin
BGC0001236.1|Thiotetroamide_9 # 19460 # 20794 # -1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.679	BGC0001236.1|Thiotetroamide_9 	19460	20794	-	Loose	660	40.0466	MexS	26.11	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAAGGAAATAGTCGATGCCATCGTCTCCACCGAGGCGACGTCCGACGACTACGCGGCGCTGCCACTCCCGGACAGCTATCGCGGCATCGCCGTCCGCAAGGCTGACACCGGAATGTTCGATGGGCTGGACTCGGGGGTGAAGGACCCACGCAAGTCCCTTCACCTCATGGAAGCTCCGGTGCCCGAGCTCGGCCCGGGCGAGGCGCTGGTCGCCGTCATGGCCTCCTCCGTGAACTACAACTCGGTGTGGACCTCGATCTTCGAGCCGCTGCCGACGTTCGGCTTCCTGGAGCGCTACGGCCGCACCAGCGAGCTGGCCAAGCGCCACGACCTGCCGTACCACATCATCGGCTCCGACCTCGCGGGCGTCGTCCTGCGCACCGGCCCCGGTGTCAACGCCTGGCACCCCGGCGACGAGGTCGTCGCGCACTGCCTGTCCGTGGAGCTGGAGTCCAGCGACGGCCACAACGACACGATGCTCGACCCCGAGCAGCGCATCTGGGGCTTCGAGACGAACTTTGGCGGCCTGGCCGAGATCGCGCTGGTCAAGTCCAACCAGCTGATGCCCAAGCCCGGCCACCTCAGCTGGGAGGAGGCCGCCGCCCCCGGTCTGGTCAACTCCACCGCCTACCGCCAGCTGGTCTCCCGCAACGGCGCCGGCATGAAGCAGGGCGACAACGTGCTCATCTGGGGCGCGAGCGGCGGACTCGGCTCGTACGCCACGCAGTTCGCGCTGGCCGGCGGCGCCAACCCGATCTGTGTCGTGTCGAGCGAGCAGAAGGCGGACATCTGCCGGGCGATGGGTGCCGAGGCGATCATCGACCGCAACGCCGAGGGCTACCAGTTCTGGAAGGACGAGCACACCCAGGACCCGAAGGAGTGGAAGCGCTTCGGCAAGCGCATCCGTGAACTCACCGGCGGGGAGGACGTCGACATCGTCTTCGAGCACCCGGGCCGCGAGACCTTCGGCGCCTCCGTCTACGTCACCCGCAAGGGCGGCACCATCGTCACCTGCGCCTCGACGTCCGGCTACACCCACGAGTACGACAACCGCTACCTGTGGATGTCGCTGAAGCGCATCATCGGCTCGCACTTCGCCAACTACCGCGAGGCGTGGGAGGCCAACCGCCTGATCGCCAAGGGCAAGATCCACCCGACGCTCTCGAAGGTCTACCCCCTCGAAGAGACCGGGCAGGCCGCCTACGACGTGCACCGCAACCTGCACCAGGGCAAGGTCGGCGTGCTGTGCCTGGCACCCGAGGAGGGCCTGGGCGTGCGCGACCACGACAAGCGCGCCCAGCACATCGACGCCATCAACCGCTTCCGGCCGTGA	VKEIVDAIVSTEATSDDYAALPLPDSYRGIAVRKADTGMFDGLDSGVKDPRKSLHLMEAPVPELGPGEALVAVMASSVNYNSVWTSIFEPLPTFGFLERYGRTSELAKRHDLPYHIIGSDLAGVVLRTGPGVNAWHPGDEVVAHCLSVELESSDGHNDTMLDPEQRIWGFETNFGGLAEIALVKSNQLMPKPGHLSWEEAAAPGLVNSTAYRQLVSRNGAGMKQGDNVLIWGASGGLGSYATQFALAGGANPICVVSSEQKADICRAMGAEAIIDRNAEGYQFWKDEHTQDPKEWKRFGKRIRELTGGEDVDIVFEHPGRETFGASVYVTRKGGTIVTCASTSGYTHEYDNRYLWMSLKRIIGSHFANYREAWEANRLIAKGKIHPTLSKVYPLEETGQAAYDVHRNLHQGKVGVLCLAPEEGLGVRDHDKRAQHIDAINRFRP	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	130.97	gnl|BL_ORD_ID|1039|hsp_num:0	1041			33	585	ciprofloxacin; trimethoprim; chloramphenicol
BGC0001236.1|Thiotetroamide_11 # 21246 # 21806 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.631	BGC0001236.1|Thiotetroamide_11 	21246	21806	+	Loose	200	25.7942	vanT gene in vanN cluster	34.78	3002975	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGGCTGACCGCGTTGTCGAGGCGGTGGGTCCGCGACTCGACGGCCCCTACGCCTTGTTCGGGCACAGCATGGGCGCAACGCTCGCATACGAGGTCGCGCTGAGGTTGCAGTCGAGCGGCCGACAGCCCGAGGCCCTCTTCGTCTCGGGACGACCTGCCCCCCACCGCAACGTCGACAAGGGGCTGCACCGGCTCTCGGACGAGGAGATAGCCGAGGACATCCGGGCGCTCGACGGCACTGGTTCGGAGATGTTCGGCGACGCGGACATACTCAAGATGTTCCTCCCGGCGATTCGCAGCGATTATCACGCTGCGGAGACGTACGAATACGTGCCCGGCACCGTTCTGAAATGCCCCATCCGCGGCTTCACGGGGTTCTCGGATCCACGGGTGGAAGTCAGTGAACTGCACCACTGGGGTGATCACACGGAGGGATCTTTCACGCTGGATGTCTTCTCGGGAGGTCACTTCTATCTCGTTGACGAGCAGGAAGGCATCGCCAGTGAAATTGAGCGCACCCTGTGTGGCGCCGGGCACCCGCAAGGAAACATGGGATTGTGA	MADRVVEAVGPRLDGPYALFGHSMGATLAYEVALRLQSSGRQPEALFVSGRPAPHRNVDKGLHRLSDEEIAEDIRALDGTGSEMFGDADILKMFLPAIRSDYHAAETYEYVPGTVLKCPIRGFTGFSDPRVEVSELHHWGDHTEGSFTLDVFSGGHFYLVDEQEGIASEIERTLCGAGHPQGNMGL	MKNVNTGINQFRLIAAFMVVAIHCFPFQSFSKTLDILITLTLFRTAVPFFLMVTGFYLIGPIATKRGYPAYLKIKKFLKKQVKLYVLATLIYLPLAFYSGVITFKTSVIQFFQLIFFEGVLYHLWYFPALILGVLIVYCLLQRFTLRQVLLVTFLFYLLCLGGDSWWGLARQIPVLEKSYQGIFTLMIHTRNGLFFAPFFLTLGASFHQSEWNMRTSKAKYFLLIASLGMLVESYLLHSFSSPKHDSAYLFLPVVMFFLFPLILNWQPTRVIADASTISLGIYVLHPYVIAVVHTLAKKITILNNSLIYYLCVSLLTSLIILYVHSKKKKTTKNQATFVPRTKKVLSKQAVIHNLAQINQVIPKTTKIMAVIKANAYGTDDTEFARILEQQGVDFFAVATIDEGIRLRENGIKSKILILGYTPSIRIKELAHYTLIQTIVSKEHAYSLNQQKIPISCHLKIDTGMHRLGVEPVVQEVSSLYRLPYLNIQGIYSHLGSADDRSDKGMKRTRKQISIFDYLLHELELQKIDVGVTHLQSSYGILNYPELVYDYVRPGILLYGYLSEHNGDSKINLNLQPILDVQALLVSKKWVAAGEYLGYSLDTKLVSPKLIGIVSIGYADGVPRELSHNEFYLAYQGQNLPQIGRICMDMLLVDLTDSPEIKVESQISIFPELEQTANQTNTLTNEIISRLGNRFYTEWS	26.57	gnl|BL_ORD_ID|4745|hsp_num:0	1983			1371	1440	vancomycin
BGC0001236.1|Thiotetroamide_12 # 21887 # 22816 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.697	BGC0001236.1|Thiotetroamide_12 	21887	22816	+	Loose	750	29.6462	MIR-9	25.81	3002174	protein homolog model	n/a	n/a	monobactam; cephalosporin	antibiotic inactivation	MIR beta-lactamase	ATGGCGGCCTCGACCGGTGTCACCCCGGAGTGGATCGAACGCAAGACGGGCATTCTTGAGCGCCGGTACGCGGAGGATGACCAAGCGGCGTCGGACCTGGCGGCAGAAGCCGGCCGCCGAGCCCTTCAGAACGCGGGGGTCGGTCCCGCCGAGCTGAGCTGGATCATCGTCGCCACTTCCACACCCGACCAGCCCCAGCCCCCTACTGCCGCTGTCGTTCAGCGTCTGCTCGGCGCCGACCGTGCCGCCGCCTTCGACGTGAACGCCGTGTGCGCGGGATTCGTCGTCGCACTGCGGGCCGGGGCCTCCATGACCCTGGAGGACGGGCGGCACGGTGGCCGCGCGCTGGTGATCGGCAGCGACGTGTACTCACGCATCGTCGACCCATCGGATCGCCGGACCGCTCCGCTCTTCGGGGACGGGGCGGGAGCGGTGGTGCTCGGGCCGGTCGCTGAGGCGGGCGGGCTCCTCGGTGGCAGCGTGGCAACGGACAGCCGACTGCTCGACCTCATCGGCATCACGGCAGGCGGCAGCCGGCAACCCTCCTCCACCGACACCCTCGCCCGTGGCGAGCACTATTTCCGCATGCGTGGGCGCGAGGTCCGCGACTACGTGACACGGGAACTCCCGCGTGCCGTTCACGACCTGCTGACGGACCTGTCCGTACCGCCCGAAGAGATCCGCCACTTCATCCCGCATCAGGCCAACGGAGCCATGCTCCGGGACATATGGGGCCACTTGGGCCTGCCCCATGCGCACCTGCACATGCCGGTCGCCCGACACGGCAACACCGGGGCGGCTTCCATTCCCATCGCTCTGGACCACGCGCACCGCTCGGGCCGGCTGGCGGCCGGAGAACTGGTCCTGCTCGCAGGATTCGGTGGCGGAATGACCATGGGAACTTCCTTGATCTCCTGGGGCAATCGCTAG	MAASTGVTPEWIERKTGILERRYAEDDQAASDLAAEAGRRALQNAGVGPAELSWIIVATSTPDQPQPPTAAVVQRLLGADRAAAFDVNAVCAGFVVALRAGASMTLEDGRHGGRALVIGSDVYSRIVDPSDRRTAPLFGDGAGAVVLGPVAEAGGLLGGSVATDSRLLDLIGITAGGSRQPSSTDTLARGEHYFRMRGREVRDYVTRELPRAVHDLLTDLSVPPEEIRHFIPHQANGAMLRDIWGHLGLPHAHLHMPVARHGNTGAASIPIALDHAHRSGRLAAGELVLLAGFGGGMTMGTSLISWGNR	MMTKSLSCALLLSVASSAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHYFTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEIALGDPVAKYWPELTGKQWQSIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEAYGVKTNVKDMASWVIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDAKTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLANKSYPNPARVEAAYRILDALQ	81.10	gnl|BL_ORD_ID|1076|hsp_num:0	1164			300	654	
BGC0001236.1|Thiotetroamide_13 # 22851 # 24071 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.662	BGC0001236.1|Thiotetroamide_13 	22851	24071	+	Loose	450	26.5646	Streptomyces lividans otr(A)	30.0	3007127	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGGACAAGTCTCAGACACTCGCCCCCTTGCCCGCCGAGCCGCCGCCGGGCTGTCCTTTCTCCCCGCCGCAGGAATACGCGGGACTTCGTATTGAACATCCGGTCAGTCGCGTCTCGCTGCCCGACGGGAGCTGGGCGTGGCTGCTGACGCGCTATGCGGACATCCGTGGCGCTCTTTCGGACCCCCGGTTCAGTTCCGACGTAAACGCTCCGGGATTTCCCCGCAGCGGAATGGTGACCGCAGGCGAAGGCAGCAGTCTCATCCGCACCGACCCTCCTGAGCACGGTCGCCGTCGCAGGATGCTGACGCGCCCCTTCACCGTGAAGAGCGTGTCCGCGCTGCGCCCTCGCATCCAGCAGATCACCGACCAGCTGTGCGATGGGTTGGAGGAACAGAAAGGCAAGGAGGGGCCCGAGGGGTCCGTGGACCTGGTGAGGTCCCTGGCACTCCCGCTTCCGTCACTGGTCATCAGCCTGCTTCTCGGCGTGCCGTACGAAGACCGGGACCTCTTCCAGTCGATCACTGCCACTGTGCTCTCCCGGGTGAACACGGAAGAGGAGCGCACCACAGCCCGTAAGGAACTGCGCGCCTACCTGGACCACCTGGTCGCCGACAAGGAGGGGAACCCGGGCGACGACATCCTCAGCGAGCTGGTCCATGAGCGGATGCGCGAAGGCCAGTTGACCCGGGAAGAGGTGACGGGGACAGCCACGCTGCTGTTGATCGCCGGGCACGAGACCACCGCGAACATGATCGGGCTCGGCGCGCTGACGCTGATCCGCAATCCGCGGGCAGCGGACGAGCTGCGCGAGGACCCCTCCCTGATGCCGGGAGCCGTCGAGGAGCTGCTGCGTTTCCACAGCATCACGCGCAGCGGGCCGCGGCGGGCCGCGACAGCCGATGTGGAAGTGGGCGGCCAGCTCATCAAGGCGGGTGAGGGAATCGTGTGTGCCGTCGCCTCCGCCAATCGAGACCCCGAGCAGTTCCCTGACGGCGACACGTTCGACATCAGGCGTCGGAACGCCCAGCACCACATCGCCTTCGGGTACGGCGTGCATCAGTGCCTCGGTCAGTCCTTGGCACGTGCTGAGCTGGAGATTTCTCTGAACACGCTGCTGGCCCGCTTTCCGGAGCTGCGGCTGGCGGTGGAATTCGAGGATGTTCCGTTCCGCCGCGACATGTTGGTCTACGGCTGCCATGAACTCCCGGTCACCTGGTGA	MDKSQTLAPLPAEPPPGCPFSPPQEYAGLRIEHPVSRVSLPDGSWAWLLTRYADIRGALSDPRFSSDVNAPGFPRSGMVTAGEGSSLIRTDPPEHGRRRRMLTRPFTVKSVSALRPRIQQITDQLCDGLEEQKGKEGPEGSVDLVRSLALPLPSLVISLLLGVPYEDRDLFQSITATVLSRVNTEEERTTARKELRAYLDHLVADKEGNPGDDILSELVHERMREGQLTREEVTGTATLLLIAGHETTANMIGLGALTLIRNPRAADELREDPSLMPGAVEELLRFHSITRSGPRRAATADVEVGGQLIKAGEGIVCAVASANRDPEQFPDGDTFDIRRRNAQHHIAFGYGVHQCLGQSLARAELEISLNTLLARFPELRLAVEFEDVPFRRDMLVYGCHELPVTW	MRTLNIGILAHVDAGKTSLTERLLFDHGAVDRLGSVDAGDTRTVDGGIERRRGITIRSAVAAFTVGDTRVNLIDTPGHSDFVAEVERALEVLDGAVLLLSAVEGVQARTRVLMRALRRLRLPTIVFVNKIDRAGARTDGLLGDVRRLLTPHVAPLTEVADAGTPRARVTRRPPDGRTAEALAEVDTEVLAALVDGPEPTGEDVARALAARTADGSFHPLYHGSALGGQGVAELVEGLLGLIPAATPGTSGGTSGGTEPRGTVFAVRPGPAGERTAYLRLYGGEVHPRRRLTFLRRESDGRTTEVSGRVTRLDVVGGDATLTAGNIAALTVPGGLRVGDRLGGPTDRAPQFAPPTLQTLVRARHPEQAAPLRSALLALADQDPLLHARPAASGATALLLYGEVQMEVLAATLAEDFGIEAEFTPGRVRFLERPAGTDEAAEEMPWLDRTRYFATIGLRVEPGPRGSGGAFGYETELGALPRAFHQAVEETVHDTLRTGLTGAAVTDYRVTLIRSGFSSPLSTAADFRGLTPLVLRRALARAGTVLHEPYQAFEAEVPADTLAAVTALLASLGADFTGTTGGDPAWIVTGELPARRVREAELRLPGLTHGEAVWSSRPCEDRPLKAGNSGPGTGVGGHSGE	63.54	gnl|BL_ORD_ID|4808|hsp_num:0	5797			849	1119	tetracycline
BGC0001236.1|Thiotetroamide_14 # 24061 # 24366 # -1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.605	BGC0001236.1|Thiotetroamide_14 	24061	24366	-	Loose	670	25.409	oqxA	38.24	3003922	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAACCCTTTCCTCGGAAATAGTTGCGTCGAGTGCAACCTCAGTAACCAGTGCCGCCCTTCGGTGTCATTCCACCTGGATCACATCCGCAGGGCAGATGGCCATGGCGTCCTGGACGGCGTCACGCAGATCGTCGGAGGGGCGGGGTCCAGAAGGATCACGATCCCGTCCTCGTCCTGGTCGAAAATCTCCGGCGCGACCAGGACGCACTGTCCTGCGCCGCAGCACTTCTCCGTGTCGACAGAAATCTTCATGGTTCTCCTCTTCGGGTCCCAGGTCAGTGGTTGCTCACCGGTCACCAGGTGA	MNPFLGNSCVECNLSNQCRPSVSFHLDHIRRADGHGVLDGVTQIVGGAGSRRITIPSSSWSKISGATRTHCPAPQHFSVSTEIFMVLLFGSQVSGCSPVTR	MSLQKTWGNIHLTALGAMMLSFLLVGCDDSVAQNAAPPAPTVSAAKVLVKSISQWDSFNGRIEAVESVQLRPRVSGYIDKVNYTDGQEVKKGQVLFTIDDRTYRAALEQAQAALARAKTQASLAQSEANRTDKLVHTNLVSREEWEQRRSAAVQAQADIRAAQAAVDAAQLNLDFTKVTAPIDGRASRALITSGNLVTAGDTASVLTTLVSQKTVYVYFDVDESTYLHYQNLARRGQGASSDNQALPVEIGLVGEEGYPHQGKVDFLDNQLTPSTGTIRMRALLDNSQRLFTPGLFARVRLPGSAEFKATLIDDKAVLTDQDRKYVYIVDKDGKAQRRDITPGRLADGLRIVQKGLNPGDSVIVDGLQKVFMPGMPVNAKTVAMTSSATLN	25.83	gnl|BL_ORD_ID|2151|hsp_num:0	2399			174	276	tigecycline; ciprofloxacin; nitrofurantoin; trimethoprim
BGC0001236.1|Thiotetroamide_15 # 24371 # 26206 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.682	BGC0001236.1|Thiotetroamide_15 	24371	26206	+	Loose	500	26.1794	TEM-60	41.03	3000929	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam; penem	antibiotic inactivation	TEM beta-lactamase	ATGTGCGGTATTGCCGGCTGGGTTTCGTACCGTCGGGATCTGACGCAGCAGTCGCAGGTCCTCGACGCCATGACCGAGACCATGGCCTGCCGCGGTCCCGACGCACGAGGCACGTGGGCGGACCGGCACGCCGCCCTTGGCCACCGGCGGCTCGCCGTCATCGACCTGGCCGGCGGGGCGCAACCGATGAGGGTGGATACCGCAGACGGCGAAGTGGTGATGGTCTATTCAGGAGAGACCTACAACTACACCGAACTGCGCGACGAACTCCGGCGCCGCGGGCACCGTTTCACCACCGACTCGGACACCGAGGTCGTGCTCCGGGGCTATGTGGAGTGGGGCGAGGCGATCGGTGAGCACCTGAACGGCATGTTCGCCTTCGCCATCTGGGATGCGCGCACCGAGAAGCTCGTCATGGTCAGGGACAGGCTGGGCGTCAAGCCGTTCTACTACTACGAGACCGAGGACGGCATCCTCTTCGGCTCGGAGCCCAAGGCGATCCTGGCGAACCCGCTCTGCTCCGCCGTCGTCGGCCTGGACGGGCTGCGGGAGATGTTCTCCTTCGCCAAGACCCCGGGGCACGCGATCTGGGAGGGGATGCGGGAGCTGCGCCCCGGCCACGTCGCCGTGACCGACACCAACGGCTCGCGGGAGTACGCCTACTGGCGCCTTGAGGCCGACGACCACACGGACGACCAGCAGGCCACCGTCGCGCACGTCAGGGACCTGCTGGACGACATCATCTCCCGGCAGCTCGTCGCGGACGTACCCCGCTGCACGCTTCTCTCCGGCGGTCTCGACTCCTCCGTCATCACCGCGTTCGCGGCCCAGCAGCTCGGGGAGCGGGGGGAGACGGTGCGCAGCTTCAACGTGGACTTCCCGAACCAGGAGGAGAACTTCAAGGCGATCGACCTCGCCCCCACCCGGGACACCCCGTACGCGCACGCGGTGGCCGAGCACGTAGGGAGCGACCACCGGGACGTCGTGCTCCACGCCGGCGCGCTGGCCGACCCGGCGGTACGGCAGGCGGCCGTCGGCGCACGGGACTTCCCCAACGGGATCGGCGACCGCGACAACTCGATGTACCTCCTCTTCAAGGCCGTCCGTGAGCAGTCGACGGTGGCGCTCTCCGGGGAGTCGGCGGACGAGTTGTTCGGGGGCTACCCGTGGTTCCACGAAGACAGGTACCGCTACGCGGACACCTTCCCCTGGCTCGCGGGCAAGGGCTCCCTCTTCGACGCGGGCGGCCTCCTGGACGACGACCTGACACGCCGGCTCGACCTGGGGACCTACGTCCAGGATCACTACGTCAGCGCCCTGAAGGAGGTGCCGCTGAAGAAGGGCGAGACCGGCCTGGAGAAGCGGATGCGCCAGGTCTGCTATCTGAACGTGACGCGGAAGATGCAGCCCCTGCTCGACCGCAAGGACCGGATGAGCATGGCGGCCGGGCTCGAGGTACGTGTCCCGTTCTGCGACCACCGTCTCGTGCAGTACGTGTTCAACACCCCGTGGTCGCTGAAGGCGTTCGACGGCAGGGAGAAGAGCCTTCTGCGCGCAGCGACGCGCGACATGTTGCCGCCGGCCGTGGCCGACCGCAAGAAGAGCGGCTACCCCAGTACCTTCGACCCGCAGTACCTCGCGGCGATCCGGTCCCAGGTCTCCGACCTGCTCAACGGCGACCACCCGGCGCTGACACTGTGCAGCCGGGACCGCCTGAGCGAGGCGATGAAGGCGGACCAGGACACCATCAGCCTCCAGCAACGGACGGTACTGGAACGCTCGCTCGACCTGGCGACGTGGCTCGACCAGCGCAACCCGACGCTGAAGCTCGACTGA	MCGIAGWVSYRRDLTQQSQVLDAMTETMACRGPDARGTWADRHAALGHRRLAVIDLAGGAQPMRVDTADGEVVMVYSGETYNYTELRDELRRRGHRFTTDSDTEVVLRGYVEWGEAIGEHLNGMFAFAIWDARTEKLVMVRDRLGVKPFYYYETEDGILFGSEPKAILANPLCSAVVGLDGLREMFSFAKTPGHAIWEGMRELRPGHVAVTDTNGSREYAYWRLEADDHTDDQQATVAHVRDLLDDIISRQLVADVPRCTLLSGGLDSSVITAFAAQQLGERGETVRSFNVDFPNQEENFKAIDLAPTRDTPYAHAVAEHVGSDHRDVVLHAGALADPAVRQAAVGARDFPNGIGDRDNSMYLLFKAVREQSTVALSGESADELFGGYPWFHEDRYRYADTFPWLAGKGSLFDAGGLLDDDLTRRLDLGTYVQDHYVSALKEVPLKKGETGLEKRMRQVCYLNVTRKMQPLLDRKDRMSMAAGLEVRVPFCDHRLVQYVFNTPWSLKAFDGREKSLLRAATRDMLPPAVADRKKSGYPSTFDPQYLAAIRSQVSDLLNGDHPALTLCSRDRLSEAMKADQDTISLQQRTVLERSLDLATWLDQRNPTLKLD	MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDPNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTMPAAMRTTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRCALPAGWLIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW	213.64	gnl|BL_ORD_ID|1878|hsp_num:0	2040			528	639	ampicillin
BGC0001236.1|Thiotetroamide_16 # 26269 # 27084 # -1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.768	BGC0001236.1|Thiotetroamide_16 	26269	27084	-	Loose	2090	25.409	cmeB	36.73	3000784	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; cephalosporin; fusidane antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGGACTGGACAGTATGGGGCGGGCTGGCCGCCGGGCTGGTCATCGCGACCGTGACCGCCCCGGTCGGGGTGTCCGGCGCGGTGTTCCTGCTCCCGGTCCAGCTGAGCGTCCTCGGCGTGCCCAACCCGGCGGTCACCCCGACGAACCTGCTGTACAACGTGGTGGCCGGACCCGGAGCCCTGTGGCGCTACCGCCTCGACGGCGCGCTGCGCGGCGACCTCGCCCGGCGCCTGGTGCTGGGCACGCTGCCCGGCGTCGTCCTCGGCGCCACCGTCCGTGTCTTCGCCCTCCCCGGCCCGGGGGTCTTCCGGCTCCTGGCGGCCGCCCTGCTGCTGCCGCTCGGCCTGTGGCTGTTCCTGCGCGCCCTCGCCCCGGCACGCCACGGCCCGTCGCCCGCGGGTGAGTCGGCCCCGGGTGAGTCGGCCCCAGGTGAGTTGGCCCCGCACATGCTGACCGGCCTCGCGCTGGCGGTCGGCGTGGTCGGCGGCATCTACGGCATCGGCGGCGGCTCCCTGCTCGGCCCGATCCTCGTCGGACGCGGCCTGCCCGTCGCCCGCGTCGCCCCGGCCGCGCTCGCCGCCACGTTCGCCACGTCGCTCGTCGGCGCCGGCACCTACGCGCTGCTGTCGTTTTTCAGTTCGGGAGACGTCGCCCCCGACTGGTGGCTCGGCCTCGCCTGCGGCACGGGCGGCCTCATGGGCGGCTACCTCGGCGCCCGCCTCCAGCCCCGCCTGCCCGACCGAGCCCTACGCCTCCTGCTCGGCGCCCTCGCCACGGCCGTCGGCGCGCTGTACGCCGCCCAGACCCTGAACTGA	MDWTVWGGLAAGLVIATVTAPVGVSGAVFLLPVQLSVLGVPNPAVTPTNLLYNVVAGPGALWRYRLDGALRGDLARRLVLGTLPGVVLGATVRVFALPGPGVFRLLAAALLLPLGLWLFLRALAPARHGPSPAGESAPGESAPGELAPHMLTGLALAVGVVGGIYGIGGGSLLGPILVGRGLPVARVAPAALAATFATSLVGAGTYALLSFFSSGDVAPDWWLGLACGTGGLMGGYLGARLQPRLPDRALRLLLGALATAVGALYAAQTLN	MFSKFFIERPVFASVVAIIISLAGVIGLTNLPIEQYPSLTPPTVKVSATYTGADAQTIASTVASPIEDAINGADNMIYMDSTSSSSGTMSLTVYFDIGTDPDQATIDVNNRISAATAKMPDAVKKLGVTVRKTSSATLAAISMYSSDGSMSAVDVYNYIALNVLDELKRVPGVGDANAIGNRNYSLRIWLKPDLLNKFKITATDVISAVNDQNAQYATGKIGEEPVTQKSPYVYSITMQGRLQNPSEFENIILRTNDDGSFLRLKDIADVEIGSQQYSSQGRLNGNDAVPIIINLQSGANALHTAELVQAKMQELSKNFPKGLTYKIPYDTTKFVIESIKEVIKTFIEALILVIIVMYMFLKNFRATLIPMIAVPVSLLGTFAGLYVLGFSINLLTLFALILAIGIVVDDAIIVVENIDRILHENEQISVKDAAIQAMQEVSSPVISIVLVLCAVFIPVSFISGFVGEIQRQFALTLAISVTISGFVALTLTPSLCALFLRRNEGEPFKFVRKFNDFFDWSTSVFSAGVAYILKRTIRFVLIFCIMLGTIFYLNKAVPNSLVPEEDQGLMIGIINLPSASALHRTISEVDHISQEVLKTNGIKDAMAMIGFDLFTSSLKENAAAMFIGLQDWKDRNVSADKIAMELNKKFAFDRNASSIFIGLPPIPGLSITGGFEMYVQNKSGKSYDQIQKDVNKLVAAANQRKELSRVRTTLDTTFPQYKLIIDRDKLKHYNLNMQDVFNTMNATIGTYYVNDFSMLGKNFQVNIRAKGDFRNTQDALKNIFVRSNDGKMIPLDSFLTLQRSSGPDDVKRFNLFPAAQVQGQPAPGYTSGQAIEAIAQVAKETLGDDYSIAWSGSAYQEVSSKGTASYAFALGMIFVFLILAAQYERWLIPLAVVTAVPFAVFGSFLLVYLRGFSNDIYFQTGLLLLIGLSAKNAILIVEFAMEERFKKGKGVFEAAVAAAKLRFRPIIMTSLAFTFGVLPMIFATGAGSASRHSLGTGLIGGMIAASTLAIFFVPLFFYLLENFNEWLDKKRGKIHE	26.06	gnl|BL_ORD_ID|689|hsp_num:0	748			2904	3048	erythromycin; cefotaxime; fusidic acid
BGC0001236.1|Thiotetroamide_17 # 27169 # 28074 # -1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.738	BGC0001236.1|Thiotetroamide_17 	27169	28074	-	Loose	550	61.6178	NmcR	38.1	3003665	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	NmcA beta-lactamase	ATGACCCTCGACGTTCATGTGCGCGACCTGCGCTACTTCGTGGCGGTGGCCGAGGAACTGCACTTCACCCGAGCCGCCGAGCGCCTGTACGTGTCGCAGCCCGCGCTGAGCAAGCAGGTCCGGGCGCTGGAGCGGCAGTTGGGCATCGAGCTGTTCCGGCGCGACCGGCACGGCGTGGCCCTCACCGACGCCGGTACGGCACTGCTGCCGCACGCCCGGCGGGTGCTGGCGGACTGGGCGGAGGGGGCGGCCGCGGTGGAGGCGGCCAGGGCGGCGCAGCACAGCACGCTGGTCGTGGGCATGAGCACCAGCCCGGTCCGGGGCGGCCTGCTGCCCGCGATCCGCTCCCGCTTCACGGCCGCGCACCCGGAGGCCGTCATCCAGCTGCGGCAGGTCAACTGGGAGGACCCGAGCGCGGGCCTCGCCGACGGCGCCGCGGACGTGGCCTTCGTCTGGCTGCCGCTGCCCGGCCAGGAGCGCTACGACTGGACGGTCGTCGCCGAGGAACCGCTCATGGTCGCCCTCCCGGACACGCATCCCCTGTCCGACCGCACCGAGGTCGACTTCACGGACCTGCTCGACGAGCCGTTCCTCGCGCTGCCGAAGAGCACGGGTCCGCTGCGCGACTACTGGCTGGCCCTGGACGCCCGCGACGGCCGACCTCCCCGGATCGGCGCCGAGATCGCGAGCACGGAGGAGACGTACGAGGCTCTGACCGCCGGTCTCGGCGTGTGCCTCGTGGCCGCGGGCAACGTCCCCCTGCTCACTCTGGGCGGCGTGATCGCCCGCCCGGTACGCGGCCTCACACCCAGCCGTTACGTCCTGGCCTGGCGCCGGGAGGACGGACGACGTCCACTGGTCCGGGAGTACGCGGAGGCCTGCCGGCGGGTCACCGGGCGCTCATGA	MTLDVHVRDLRYFVAVAEELHFTRAAERLYVSQPALSKQVRALERQLGIELFRRDRHGVALTDAGTALLPHARRVLADWAEGAAAVEAARAAQHSTLVVGMSTSPVRGGLLPAIRSRFTAAHPEAVIQLRQVNWEDPSAGLADGAADVAFVWLPLPGQERYDWTVVAEEPLMVALPDTHPLSDRTEVDFTDLLDEPFLALPKSTGPLRDYWLALDARDGRPPRIGAEIASTEETYEALTAGLGVCLVAAGNVPLLTLGGVIARPVRGLTPSRYVLAWRREDGRRPLVREYAEACRRVTGRS	MRARLPLNALRAFEASARYLNFTKAGLELHVSQAAVSQQVRTLEQMLGVALFTRVPRGLQLTDEGMHLLPSITEALQMMSSAMDKFHEGKIKEVLTIAVVGTFAIGWLLPRITAFLNENPWIDIRILTHNNVVNLAAEGIDASIRFGTGGWINTENILLFQAPHTVLCSPETSKKLYIPSDLKKVCLLRSYRKEEWNNWFKAAGIDPWTITGPIFDSTRLMIDAVKLGDYAALVPYHMFQKELNERSVAKPFEIYATLGGYWLTLQKSRVNHNSEALNVFKEWIIEHSREFVLKS	102.03	gnl|BL_ORD_ID|1905|hsp_num:0	2072			27	336	cefoxitin; cefazolin; ampicillin
BGC0001236.1|Thiotetroamide_18 # 28227 # 29057 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.738	BGC0001236.1|Thiotetroamide_18 	28227	29057	+	Loose	500	26.1794	mphJ	46.15	3004544	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	ATGAACAAGGTGTGGCTGATCACGGGTGCGAGCAGCGGCTTCGGGCGGGCGATCGCCGAGGCGGCCCTCGCCGCGGGCGACGTGGTGGTCGGCGCGGCCCGGCGCCCCGAGGCGTTGGACGACCTGGTCGCCGCCCACCCCGACCGGGTGGAGGCCCTGCGCCTGGACGTCGCCGACACCGGCGCCGCCGAGGCCGCCGTACGGGACGTCGTGGCGCGGCACGGGCGGATCGACGTCCTGGTCAACAACGCGGGCCGGACACATGTCGGTGCCTTCGAGGAGACCACCGAGGAGGAGCTGCGGGCGCTGTTCGAGGTGCATGTCTTCGGCCCGGCCGCCCTCACCCGGGCCGTGCTGCCGTACATGCGAGAGCGGCGGTCGGGCGCGATCGTGCAGATGAGCAGCATGGGCGGGCAGCTGTCCTTCGCGGGCTTCTCGGCCTACAGCGCGACGAAGTTCGCCCTGGAGGGCATGTCCGAGGGACTCGCGGACGAGGTCGCGGAGTTCGGCGTCAAGGTGCTGATCGTCGAGCCGGGCGCGTTCCGCACGGGCCTGTTCGCGACCGGGCGGGCCGGTGCCAGTGCGGACAGCGGCGTGTACGGCAAGGTGAGCGAGACCCGTGGCCTCGTCGCCGGCGGCGACGGCACCCAGCCGGGCGACCCGGCCAAGGCCGCCGCCCTCATCCTGGCCGCGCTCGACGCCGATTCCACGCCGCTGCGCCTGCCCCTCGGGGACGACGGCGTCAGCGCGGTCCTCGCCCATCTCGACCAGGTACGCGACGAGGTCCTGGCATGGGAGAAGCGGTCCCGGGCCACGGGGTTCGACGACTGA	MNKVWLITGASSGFGRAIAEAALAAGDVVVGAARRPEALDDLVAAHPDRVEALRLDVADTGAAEAAVRDVVARHGRIDVLVNNAGRTHVGAFEETTEEELRALFEVHVFGPAALTRAVLPYMRERRSGAIVQMSSMGGQLSFAGFSAYSATKFALEGMSEGLADEVAEFGVKVLIVEPGAFRTGLFATGRAGASADSGVYGKVSETRGLVAGGDGTQPGDPAKAAALILAALDADSTPLRLPLGDDGVSAVLAHLDQVRDEVLAWEKRSRATGFDD	MSKNNVEHMLALAKNNGILVDPTTVKVNESGLDFLAIFASTIDGIPWVLRQPRRDDVVETARYEKRVLDLVAKHLRVEVPDWQVHTSEFIAYPILGGTPMATINMETKNYDWYLNPESLPELCIQTWAEALVELHGIHHDLARDAGIRVKQPSYARASLREKMNEIKRVFGVSGALWDRWQKWLADETFWPAHSALVHGDLHPGHILVAENGKVTGLLDWTEAEVSDPAIDFTVVYLLFGDTGLADFIQRYEKAGGRVWSRMHEHIVEMTAAYPVTLATFALKSGLEEFKIMARQALGVDENGKEITS	89.61	gnl|BL_ORD_ID|2691|hsp_num:0	3220			159	237	erythromycin; telithromycin; tylosin
